How patients with multiple sclerosis acquire disabilityFred Lublin, Robert A Bermel, Douglas L. Arnold et al.|Brain|2022Cited by 532
The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosisP. D. Molyneux, D. H. Miller, Ludwig Kappos et al.|Brain|2000Cited by 241
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 studyKrzysztof Selmaj, Erik Wallström, David K.B. Li et al.|The Lancet Neurology|2013Cited by 233
Interferon beta-1b in secondary progressive MSLudwig Kappos, Henry F. McFarland, Brian G. Weinshenker et al.|Neurology|2004Cited by 223
Can the Expanded Disability Status Scale be assessed by telephone?Jeannette Lechner‐Scott, Robert Gibberd, Ludwig Kappos et al.|Multiple Sclerosis Journal|2003Cited by 143